$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Oct 14, 2025)
$3.05B
Market Cap
-
P/E Ratio
-1.83
EPS
$35.72
52 Week High
$16.10
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Apellis Pharmaceuticals, Inc. is an innovative clinical-stage biopharmaceutical company based in Waltham, Massachusetts, specializing in therapeutic compounds that target the complement system to address various autoimmune and inflammatory diseases. With a robust portfolio of product candidates, Apellis aims to transform the treatment landscape for patients suffering from these challenging conditions. The company's leading asset highlights its commitment to harnessing novel therapeutic mechanisms, positioning it as a key player in the evolving biopharmaceutical sector.